Mucormycosis: "" trampling post-COVID-19 patients.
作者信息
Gupta Ambika, Singh Virendra
机构信息
Department of Oral Medicine and Radiology, PGIDS, Pt. B. D. Sharma University of Health Sciences, Rohtak, Haryana, India.
Department of Oral and Maxillofacial Surgery, PGIDS, Pt. B. D. Sharma University of Health Sciences, Rohtak, Haryana, India E-mail:
出版信息
Natl J Maxillofac Surg. 2021 May-Aug;12(2):131-132. doi: 10.4103/njms.njms_415_21. Epub 2021 Jul 15.
Abstract
摘要
相似文献
1
Mucormycosis: "" trampling post-COVID-19 patients.毛霉菌病：“新冠后患者的‘践踏’” 。 （此翻译可能因原文表述不太清晰准确而显得有些奇怪，建议你进一步确认原文的准确含义和完整内容，以便能得到更精准的译文 ）
Natl J Maxillofac Surg. 2021 May-Aug;12(2):131-132. doi: 10.4103/njms.njms_415_21. Epub 2021 Jul 15.
2
Mucormycosis and COVID-19 an epidemic in a pandemic?毛霉菌病与新冠疫情——大流行中的一种流行病？
Nepal J Epidemiol. 2021 Jun 30;11(2):1034-1039. doi: 10.3126/nje.v11i2.37342. eCollection 2021 Jun.
3
Mucormycosis (black fungus) infection and misuse of corticosteroids in COVID 19 patients in Syria.叙利亚新冠肺炎患者的毛霉菌病（黑真菌）感染及皮质类固醇的不当使用
Ann Med Surg (Lond). 2022 Mar;75:103463. doi: 10.1016/j.amsu.2022.103463. Epub 2022 Mar 9.
4
The "black fungus" through a gray lens: Imaging COVID-19-associated mucormycosis.透过灰色镜片看“黑真菌”：新型冠状病毒肺炎相关毛霉菌病的影像学表现
Indian J Ophthalmol. 2021 Jul;69(7):1648-1649. doi: 10.4103/ijo.IJO_1506_21.
5
Fungal Taxa Responsible for Mucormycosis/"Black Fungus" among COVID-19 Patients in India.印度新冠肺炎患者中导致毛霉病/“黑真菌病”的真菌分类群
J Fungi (Basel). 2021 Aug 7;7(8):641. doi: 10.3390/jof7080641.
6
Mucormycosis (Mucor fungus ball) of the maxillary sinus.上颌窦毛霉菌病（毛霉菌球）
Ear Nose Throat J. 2014 Oct-Nov;93(10-11):E18-22.
7
Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.在 COVID-19 特定的三级护理重症监护病房中，严格遵循方案驱动管理的情况下，（2020 年 3 月至 2021 年 5 月）未发生毛霉菌病病例。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102169. doi: 10.1016/j.dsx.2021.06.006. Epub 2021 Jun 9.
8
Impacts of experimental trampling on tall alpine herbfields and subalpine grasslands in the Australian Alps.实验性踩踏对澳大利亚阿尔卑斯山高山草本植物区系和亚高山草原的影响。
J Environ Manage. 2009 Nov-Dec;91(2):532-40. doi: 10.1016/j.jenvman.2009.09.022. Epub 2009 Oct 24.
9
Mucor in a Viral Land: A Tale of Two Pathogens.霉菌在病毒之地：两种病原体的故事。
Indian J Ophthalmol. 2021 Feb;69(2):244-252. doi: 10.4103/ijo.IJO_3774_20.
10
Rhinocerebral Mucormycosis and COVID-19 Pneumonia.鼻脑型毛霉菌病与新型冠状病毒肺炎
J Med Cases. 2021 Mar;12(3):85-89. doi: 10.14740/jmc3637. Epub 2021 Jan 19.
引用本文的文献
1
Dermatological complications due to post‑COVID‑19 syndrome: A systematic review.新冠后综合征导致的皮肤并发症：一项系统综述。
Med Int (Lond). 2024 Nov 26;5(1):9. doi: 10.3892/mi.2024.208. eCollection 2025 Jan-Feb.
2
Simulating the Morphological Changes of Facial Deformities after Using 3D-printed Polyether Ether Ketone Facial Implants.模拟使用3D打印聚醚醚酮面部植入物后面部畸形的形态变化。
Plast Reconstr Surg Glob Open. 2024 Aug 6;12(8):e6029. doi: 10.1097/GOX.0000000000006029. eCollection 2024 Aug.
3
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19.关注 COVID-19 相关毛霉菌病：免疫功能低下 COVID-19 的一大威胁。
Environ Sci Pollut Res Int. 2023 Jan;30(4):9164-9183. doi: 10.1007/s11356-022-24032-2. Epub 2022 Dec 1.
本文引用的文献
1
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.冠状病毒病（新冠-19）相关毛霉菌病（CAM）：病例报告及文献系统综述
Mycopathologia. 2021 May;186(2):289-298. doi: 10.1007/s11046-021-00528-2. Epub 2021 Feb 5.
2
COVID-19 infection may cause ketosis and ketoacidosis.COVID-19 感染可能导致酮症和酮酸中毒。
Diabetes Obes Metab. 2020 Oct;22(10):1935-1941. doi: 10.1111/dom.14057. Epub 2020 May 18.
3
Invasive fungal diseases during COVID-19: We should be prepared.2019冠状病毒病期间的侵袭性真菌病：我们应做好准备。
J Mycol Med. 2020 Jun;30(2):100971. doi: 10.1016/j.mycmed.2020.100971. Epub 2020 Apr 6.
4
Pathogenesis of mucormycosis.毛霉病的发病机制。
Clin Infect Dis. 2012 Feb;54 Suppl 1(Suppl 1):S16-22. doi: 10.1093/cid/cir865.
5
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey.印度糖尿病和糖耐量受损的高患病率：全国城市糖尿病调查
Diabetologia. 2001 Sep;44(9):1094-101. doi: 10.1007/s001250100627.
Zotero 插件